NewsWhore
06-04-2008, 06:10 PM
LONDON – Drug maker AstraZeneca PLC said Wednesday it has applied for U.S. approval to market its asthma treatment Symbicort for children aged 6 to 11. The application submitted to the U.S. F...
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/15288962/)
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/15288962/)